Abstract:BACKGROUND AND AIMS: Liver and systemic inflammatory factors influence monocyte phenotype and function, which has implications for hepatic recruitment and subsequent inflammatory and fibrogenic responses, as well as host defence.METHODS: Peripheral blood monocyte surface marker (CD14, CD16, CD163, CSF1R, CCR2, CCR4, CCR5, CXCR3, CXCR4, CX3CR1, HLA-DR, CD62L, SIGLEC-1) expression and capacity for phagocytosis, oxidative burst and LPS-stimulated TNF production were assessed in patients with hepatitis C (HCV) (n = 39) or non-alcoholic fatty liver disease (NAFLD) (n = 34) (classified as non-advanced disease, compensated cirrhosis and decompensated cirrhosis) and healthy controls (n = 11) by flow cytometry.RESULTS: The selected markers exhibited similar monocyte-subset-specific expression patterns between patients and controls. Monocyte phenotypic signatures differed between NAFLD and HCV patients, with an increased proportion of CD16+ non-classical monocytes in NAFLD, but increased expression of CXCR3 and CXCR4 in HCV. In both cohorts, monocyte CCR2 expression was reduced and CCR4 elevated over controls. CD62L expression was specifically elevated in patients with decompensated cirrhosis and positively correlated with the model-for-end-stage-liver-disease score. Functionally, monocytes from patients with decompensated cirrhosis had equal phagocytic capacity, but displayed features of dysfunction, characterised by lower HLA-DR expression and blunted oxidative responses. Lower monocyte TNF production in response to LPS stimulation correlated with time to death in 7 (46%) of the decompensated patients who died within 8 months of recruitment.CONCLUSIONS: Chronic HCV and NAFLD differentially affect circulating monocyte phenotype, suggesting specific injury-induced signals may contribute to hepatic monocyte recruitment and systemic activation state. Monocyte function, however, was similarly impaired in patients with both HCV and NAFLD, particularly in advanced disease, which likely contributes to the increased susceptibility to infection in these patients.

Altered Monocyte Responses to Defined TLR Ligands in Patients with Primary Biliary Cirrhosis

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

IL-17A produced by invariant natural killer T cells and CD3(+)CD56(+)alpha Galcer-CD1d tetramer(-) T cells promote liver fibrosis in patients with primary biliary cholangitis

IL-17A produced by invariant natural killer T cells and CD3+CD56+αGalcer-CD1d tetramer– T cells promote liver fibrosis in patients with primary biliary cholangitis

Altered Immune Function Of Monocytes In Different Stages Of Patients With Acute On Chronic Liver Failure

Liver-targeted and Peripheral Blood Alterations of Regulatory T Cells in Primary Biliary Cirrhosis

Analysis of Altered Microrna Expression Profiles in Peripheral Blood Mononuclear Cells from Patients with Primary Biliary Cirrhosis.

The Modulation of Co-Stimulatory Molecules by Circulating Exosomes in Primary Biliary Cirrhosis

Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis.

TCRβ Repertoire of Memory T cell Reveals Potential Role for E.coli in the Pathogenesis of Primary Biliary Cholangitis.

Tcr Beta Repertoire Of Memory T Cell Reveals Potential Role For Escherichia Coli In The Pathogenesis Of Primary Biliary Cholangitis

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation

Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)

Dysregulation of Peritoneal Cavity B1a Cells and Murine Primary Biliary Cholangitis

Immunological Abnormalities in Patients with Primary Biliary Cholangitis

The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis

The Proinflammatory Cytokines IL-18, IL-21, and IFN-γ Differentially Regulate Liver Inflammation and Anti-Mitochondrial Antibody Level in a Murine Model of Primary Biliary Cholangitis

The Critical Role of Th1 Cytokine Polarization in Murine Primary Biliary Cirrhosis. (P4154)

Increased Killing Activity and Decreased Cytokine Production in NK Cells in Patients with Primary Biliary Cirrhosis

Bacterial Cpg Induces Hyper-Igm Production in Cd27(+) Memory B Cells in Primary Biliary Cirrhosis

Increased Levels of Chemokine Receptor CXCR3 and Chemokines IP-10 and MIG in Patients with Primary Biliary Cirrhosis and Their First Degree Relatives.